შაბათი, მაისი 2, 2026
- Advertisement -
Google search engine
Global Ingredient Risk Index Botanical

Acerola Cherry

Malpighia emarginata

Also known as: Barbados cherry, West Indian cherry, acerola, natural vitamin C

LOW RISK 1.5/10 How?

This ingredient is classified as unclassified risk (GIRI score: 1.5/10).

02

Safety Profile

Known Safety Concerns

  • High-dose GI upset and diarrhea
  • Oxalate content -- caution in kidney stone history
  • Naturally high vitamin C -- monitor total intake

Contraindications

  • High-dose GI upset and diarrhea
  • Oxalate content -- caution in kidney stone history
═══════════════════════════════════════════════════════════════════════ -->
03

Interactions

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
04

Evidence and Scientific Findings

Overview

Ingredient Overview

Acerola is exceptionally rich in natural ascorbic acid (vitamin C). At supplemental doses, generally safe. High doses may cause gastrointestinal upset and osmotic diarrhea consistent with excess vitamin C. Oxalic acid content may contribute to kidney stone risk in susceptible individuals.

Classification

Biological and Chemical Classification

Scientific Name
Malpighia emarginata
Mechanism

Mechanism of Action

Information not yet available for this ingredient profile.

Clinical Evidence

Clinical Evidence of Effectiveness

Information not yet available for this ingredient profile.

Pharmacokinetics

Pharmacokinetics

Information not yet available for this ingredient profile.

Dosage

Recommended Dosage

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
05

SETI — Scientific Evidence Transparency Index

SETI Score 50/100
Risk Level High risk
Scientific Confidence Low
Evidence Strength Limited
Key Benefit Botanical
Key Safety Concern High-dose GI upset and diarrhea
Evidence Reviewed 10 PubMed studies
Scientific Confidence Low
Based on study quality, consistency, and recency

Executive Summary — Ingredient Assessment

SETI Score 50/100
Risk Level High risk
Evidence Strength Limited
Main Benefit Botanical
Main Safety Concern High-dose GI upset and diarrhea
Ingredient Acerola Cherry
Scientific name Malpighia emarginata
Scientific Evidence Overview
  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or RCT)
  • Main clinical benefit observed: Botanical
  • Evidence consistency: High consistency across studies (100%)
Safety Signals
  • High-dose GI upset and diarrhea
  • Oxalate content -- caution in kidney stone history
  • Naturally high vitamin C -- monitor total intake
Evidence Strength Limited
Final Scientific Assessment

The available scientific evidence for Acerola Cherry indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.

Ingredient Acerola Cherry
Evidence reviewed 10 peer-reviewed studies (last 10 years)
Scientific name Malpighia emarginata
50 /100

Total SETI Score

High risk
Evidence quality 10/40
Evidence consistency 20/20
Safety signals 0/20
Study recency 10/10
Evidence transparency 10/10

Evidence Summary

  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or systematic review)
  • 0 studies identified benefits or no safety concern (GREEN)
  • 10 studies reported limited or advisory safety evidence (YELLOW)

Evidence Policy

Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.

Last updated: 25 მარ 2026, 22:28

Evidence Distribution

10 Other / unclassified
  1. Observational / other LOW evidence YELLOW
    Mathematical Modeling and Physicochemical Characterization of Foam-Mat Drying of Acerola (Malpighia emarginata) Pulp. ↗
    Journal Foods
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Manu00e7ano LF et al.. Mathematical Modeling and Physicochemical Characterization of Foam-Mat Drying of Acerola (Malpighia emarginata) Pulp.. Foods. 2026. PMID:41683080.
  2. Observational / other LOW evidence YELLOW
    Optimization of spray-drying conditions for green acerola concentrate juice: effect of temperature and maltodextrin. ↗
    Journal J Sci Food Agric
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Costa FS et al.. Optimization of spray-drying conditions for green acerola concentrate juice: effect of temperature and maltodextrin.. J Sci Food Agric. 2026. PMID:41312762.
  3. Observational / other LOW evidence YELLOW
    Fruit flies (Diptera: Tephritidae) and their parasitoids associated with a commercial acerola orchards in Parnau00edba River Valley, Brazil. ↗
    Journal Neotrop Entomol
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Rocha LLGO et al.. Fruit flies (Diptera: Tephritidae) and their parasitoids associated with a commercial acerola orchards in Parnau00edba River Valley, Brazil.. Neotrop Entomol. 2025. PMID:41329301.
  4. Observational / other LOW evidence YELLOW
    Detection of adulteration in acerola (Malpighia emarginata DC.) pulps using a portable near-infrared (nir) spectrophotometer and chemometric. ↗
    Journal Food Res Int
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Dutra JWA et al.. Detection of adulteration in acerola (Malpighia emarginata DC.) pulps using a portable near-infrared (nir) spectrophotometer and chemometric.. Food Res Int. 2025. PMID:41174408.
  5. Observational / other LOW evidence YELLOW
    Salicylic Acid Reduces Salinity Stress in Barbados Cherry Irrigated with Oilfield Water in Semiarid Brazil. ↗
    Journal ACS Omega
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Gomes Nobre R et al.. Salicylic Acid Reduces Salinity Stress in Barbados Cherry Irrigated with Oilfield Water in Semiarid Brazil.. ACS Omega. 2025. PMID:41114186.
  6. Observational / other LOW evidence YELLOW
    Adsorption and nanoencapsulation: Innovative strategies for recovery and protection of flavonoids from Malpighia emarginata DC. (acerola) pomace extract. ↗
    Journal Food Chem
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Freitas EES et al.. Adsorption and nanoencapsulation: Innovative strategies for recovery and protection of flavonoids from Malpighia emarginata DC. (acerola) pomace extract.. Food Chem. 2025. PMID:40554273.
  7. Observational / other LOW evidence YELLOW
    Efficiency of Ozonated Water Treatment with a Microbubble System for Sanitization and Preservation of Postharvest Quality of Acerolas. ↗
    Journal Foods
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Gonu00e7alves-Magalhu00e3es C et al.. Efficiency of Ozonated Water Treatment with a Microbubble System for Sanitization and Preservation of Postharvest Quality of Acerolas.. Foods. 2025. PMID:40428593.
  8. Observational / other LOW evidence YELLOW
    Multiple targets directed screening of compounds from northeastern Brazilian fruits with activity in oxidative stress pathways associated with vascular damage throughout ageing. ↗
    Journal Nat Prod Res
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Menezes GMS et al.. Multiple targets directed screening of compounds from northeastern Brazilian fruits with activity in oxidative stress pathways associated with vascular damage throughout ageing.. Nat Prod Res. 2025. PMID:40337800.
  9. Observational / other LOW evidence YELLOW
    Efficiency of pantraps for monitoring bees diversity in Brazilian acerola orchards: the role of color diversity. ↗
    Journal An Acad Bras Cienc
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Coelho MS et al.. Efficiency of pantraps for monitoring bees diversity in Brazilian acerola orchards: the role of color diversity.. An Acad Bras Cienc. 2025. PMID:40136199.
  10. Observational / other LOW evidence YELLOW
    Acerola-Derived Photorepair System for Eliminating Ultraviolet-Induced Pyrimidine Dimers in Human Cells. ↗
    Journal Nutrients
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Yanagimachi M et al.. Acerola-Derived Photorepair System for Eliminating Ultraviolet-Induced Pyrimidine Dimers in Human Cells.. Nutrients. 2025. PMID:40077662.
═══════════════════════════════════════════════════════════════════════ -->
06

Score Transparency

Q × L × D × S × 10 = 1.5 / 10

The GIRI Score is the product of four independently computed evidence components, each normalised to 0–1, then scaled to 0–10. Every component is derived exclusively from peer-reviewed references and regulatory data — no editorial judgement is applied.

Q
Evidence Quantity 0 / 10
0%

0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.

Method: Q = number of approved references ÷ 10 (capped at 1.0)

L
Evidence Quality 5 / 10
50%

Limited — mostly case reports or animal studies

Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.

D
Evidence Direction 5 / 10
Benefit
Risk
50%

Mixed or neutral — roughly equal benefit and risk signals

Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.

S
Safety Signals 5 / 10
50%

One or more monitoring-level safety signals active

Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.

0Q × 5L × 5D × 5S = 1.5 / 10

Final GIRI Score for Acerola Cherry. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Full methodology & data sources

The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.

  • References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
  • Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
  • Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
  • Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
07

Risk Level Classification

LOW RISK 1.5/10

Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.

LOW
0–3.0
MODERATE
3.0–5.5
HIGH
5.5–7.5
CRITICAL
7.5–10
1.5

The score pin shows exactly where this ingredient falls on the fixed risk scale.

What drove the Low classification for Acerola Cherry

GIRI Score 1.5 / 10

A score of 1.5 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Evidence Quantity (Q) 0 / 10 refs

0 approved references.

Evidence Quality (L) 50%

Limited — mostly case reports or animal studies (Level 4–5).

Evidence Direction (D) 50% toward risk

Neutral or mixed — benefit and risk signals roughly balanced.

Safety Signals (S) 0 active signals

No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.

Regulatory Status No restrictions found

No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).

How are the Low / Moderate / High / Critical thresholds defined?

The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:

LevelScoreMeaning
LOW0.0 – 2.9Sparse or predominantly beneficial evidence. No active safety alerts.
MODERATE3.0 – 5.4Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups.
HIGH5.5 – 7.4Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended.
CRITICAL7.5 – 10Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision.

Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.

შენიექიმი
sheniekimi.ge · PHIG
გამარჯობა 👋
სასურველი სერვისი აირჩიეთ ქვემოთ
⚡ გადაუდებელი შემთხვევა?
მყისიერი სამედიცინო დახმარება
📞 112
🩺
სიმპტომების შეფასება
150 კლინიკური სცენარი · WHO · AHA · NICE · 29 CDR
💉
ვაქცინაციის კალენდარი
WHO · ECDC · NCDC საქართველო 2025
💊
დანამატების შემოწმება
supplement.ge — 2,095 ინგრედიენტი
ℹ️ეს სისტემა ახდენს ტრიაჟს — არა დიაგნოზს. ყოველი გადაწყვეტილება დაფუძნებულია WHO, AHA, NICE, BTS სახელმძღვანელოებზე. ექიმის კონსულტაცია სავალდებულოა.
პირადი ინფორმაცია
სიმპტომების ზუსტი შეფასებისთვის შეიყვანეთ ასაკი და სქესი
👤სავალდებულო
📏 ანთროპომეტრია
სიმაღლე · წონა · BMI — არასავალდებულო
🩺 სასიცოცხლო მაჩვენებლები
წნევა · პულსი · ტემპერატურა · SpO2 — არასავალდებულო
ნორმა: 90–129
ნორმა: 60–100
36–37.2
12–20
≥95%
სიმპტომების შეფასება
აირჩიეთ სცენარი სისტემის მიხედვით
🔍
კითხვა 1 / 1
📋 მტკიცებულებითი საფუძველი
World Health Organization (WHO) — IMAI სახელმძღვანელო
American Heart Association (AHA) / ACC
National Institute for Health and Care Excellence (NICE)
ICD-11 (2025) · World Health Organization
ეს ინსტრუმენტი ახდენს ტრიაჟს — არა დიაგნოზს. სიმპტომები შეიძლება მიუთითებდეს — ეს არ ნიშნავს, რომ დაავადება გაქვთ. ექიმის კონსულტაცია სავალდებულოა.
📰 სიახლეები ყველა ›
ვაქცინაციის კალენდარი
აირჩიეთ ასაკობრივი ჯგუფი
WHO ECDC NCDC 2025
📚წყარო: NCDC საქართველო 17.09.2025 · WHO · ECDC
ასაკობრივი ჯგუფი
📚წყარო: NCDC საქართველო 17.09.2025 · WHO · ECDC
📰 ვაქცინაციის სიახლეები ყველა ›
დანამატების შემოწმება
გადადით supplement.ge-ზე და შეამოწმეთ ნებისმიერი პროდუქტი
SUPPLEMENT.GE
საქართველოს სასურსათო დანამატების უსაფრთხოების შემოწმების სისტემა
📊 2,095 ინგრედიენტი 📦 688 პროდუქტი
supplement.ge-ზე გადასვლა
ახალი ფანჯარა გაიხსნება
რას შეგიძლიათ შეამოწმოთ
🔬
ინგრედიენტის შემოწმება
NIH · EU · FDA · Health Canada მონაცემები
📷
ეტიკეტის სკანირება
AI ამოიცნობს ყველა ინგრედიენტს ფოტოდან
🌍
ქვეყნის მიხედვით სტატუსი
რეგულაცია 14 ქვეყანაში — აშშ, ევროკავშირი, კანადა
⚠️
წამალთან ინტერაქცია
აუცილებელი გაფრთხილებები მიმდინარე მკურნალობისას
✅ supplement.ge — საქართველოში ერთადერთი სრული სისტემა დანამატების უსაფრთხოების შესაფასებლად, PHIG-ის (საზოგადოებრივი ჯანდაცვის ინსტიტუტის) კონტროლით.